What does Transverse Medical do?
Transverse Medical is an early-stage medical device company developing the Point-Guard cerebral embolic protection system designed to prevent strokes during transcatheter aortic valve replacements (TAVR).
How much did they raise?
The company raised $10M in a Series B2 funding round, with participation from its Legacy Lead investor and Series B1 investors, underscoring continued investor confidence.
What are their plans for the money?
The funds will be used to expand operational infrastructure and grow engineering, regulatory, quality, and operating teams, as the company advances toward pivotal clinical trials and an FDA IDE submission, potentially accelerating the development and commercialization of its device.
What have they achieved so far?
Transverse Medical has already achieved a significant milestone with the development of its Point-Guard device, positioning it well for upcoming clinical trials and regulatory approval.
